Raid: Raebareli Pharma agency sealed over purchase of 1.4 lakh bottles of codeine syrup

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-10-14 08:37 GMT   |   Update On 2025-10-14 09:40 GMT
Advertisement

Raebareli: In a major bust, authorities sealed the Ajay Pharma Agency in Raebareli, Uttar Pradesh, on Tuesday after discovering that the company purchased 1.40 lakh bottles of codeine-based cough syrup, a controlled substance linked to addiction and fatal effects.

The raid, carried out by a team of drug inspectors, reveals a disturbing trade in controlled substances, as the agency purchased the stock from Lucknow-based Indica Life Sciences, located in Transport Nagar.

Advertisement

Codeine, a narcotic component used in some cough syrups, poses severe health risks, including addiction, respiratory depression, overdose, and even death.

Before the raid began, the operator of the agency reportedly locked the premises and fled. Authorities have initiated proceedings to file a case against the absconding operator.

Drug Inspector Shivendra Pratap Singh, who led the operation, sealed the premises and confirmed that strict legal action is underway.

Speaking to IANS, he said, "Information was received that a large quantity of the narcotic medicine, codeine cough syrup, was supplied from Ghaziabad Pharma via Lucknow to here. When officials reached the shop, it was closed. The owner was informed and instructed to appear."

"As soon as we conduct a detailed investigation, we will take strict action against the accused," he added.

The action comes amid a nationwide crackdown on pharmaceutical agencies found selling or distributing medicines unfit for human consumption, following the deaths of several children in Madhya Pradesh linked to the adulterated Coldrif cough syrup.

The Tamil Nadu government has permanently revoked the manufacturing licence of Sresan Pharmaceuticals, the company behind the adulterated cough syrup Coldrif, and ordered its complete shutdown following revelations that the medicine contained dangerously high levels of toxic chemicals.

In a statement, the Tamil Nadu government said, "The drug manufacturing licence of Sresan Pharmaceuticals has been completely cancelled, and the company has been shut down. Orders have also been issued to conduct a detailed inspection of all drug manufacturing units across Tamil Nadu to ensure compliance with safety and quality standards."

Officials added that the Health Department will tighten monitoring mechanisms and adopt stricter penalties for pharmaceutical firms violating public health norms.

The state Drug Control Department, during an inspection of the firm's Kancheepuram facility, found that Coldrif syrup contained 48.6 per cent diethylene glycol (DEG), a lethal industrial solvent used in antifreeze, instead of approved pharmaceutical ingredients.

Consumption of the syrup has been linked to the death of over 20 children in Madhya Pradesh's Chhindwara district, triggering outrage and nationwide scrutiny.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News